Abstract
Alzheimer's disease is the most common form of dementia that affects 50 million people worldwide (World Health Organization, 2017). In the next three decades, dementia diagnoses are predicted to drastically increase to 132 million cases globally (Alzheimer's Disease International, 2019), causing an Alzheimer's disease epidemic. The rapid increase in dementia cases is problematic, as Alzheimer's disease currently has no cure and always results in death (Alzheimer's Association, 2018). Consequentially, Alzheimer's disease is the fifth leading cause of death worldwide (Alzheimer's Association, 2018; World Health Organization, 2018). It is safe to say that Alzheimer's disease is one of the greatest medical threats of our time. Accordingly, there is a critical need for Alzheimer's disease research to overcome what is expected to be a global epidemic.
| Original language | English |
|---|---|
| Title of host publication | Alzheimer’s Disease: Understanding Biomarkers, Big Data, and Therapy |
| Editors | Ahmed A. Moustafa |
| Place of Publication | U.K. |
| Publisher | Academic Press |
| Pages | 125-149 |
| Number of pages | 25 |
| ISBN (Print) | 9780128213346 |
| Publication status | Published - 2022 |